Drug interactions.
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004077:Digoxin / Q000097:blood; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004790:Enzyme Induction / Q000187:drug effects; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D010879:Piperazines / Q000009:adverse effects / Q000493:pharmacokinetics*; D011687:Purines; D011802:Quinidine / Q000008:administration & dosage; D000068677:Sildenafil Citrate; D013450:Sulfones; D014665:Vasodilator Agents / Q000009:adverse effects / Q000493:pharmacokinetics*; D018879:Ventricular Premature Complexes; D014700:Verapamil / Q000008:administration & dosage
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D007527:Isoenzymes; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D004077:Digoxin; D003577:Cytochrome P-450 Enzyme System; D000068677:Sildenafil Citrate; D014700:Verapamil; D011802:Quinidine